autophagy-lysosomal-alzheimers

Introduction

Autophagy (meaning “self-eating”) is a cellular degradation process that maintains neuronal homeostasis by removing damaged mitochondria (mitophagy), clearing protein aggregates, eliminating intracellular pathogens, and maintaining cellular homeostasis^{1Nixon RA, The role of autophagy in neurodegenerative disease, Nature Medicine, 20132013 · PMID 24362961Open reference}. The autophagy-lysosomal pathway is essential for neuronal survival due to the post-mitotic nature of neurons, which cannot dilute damaged components through cell division^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}.

In AD, autophagy-lysosomal function is impaired at multiple levels, contributing to the accumulation of amyloid-beta (Aβ) and tau aggregates^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}. This impairment creates a vicious cycle where reduced autophagic clearance leads to toxic protein accumulation, which further disrupts cellular degradation pathways^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}.

Key Mechanisms

1. Autophagy Initiation Dysregulation

Autophagy is initiated by the ULK1 complex and Beclin-1^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}. In AD, multiple components of this initiation machinery are dysregulated:

• Beclin-1 reduction: Beclin-1 levels are significantly reduced in AD brain, impairing the nucleation step of autophagosome formation^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}

• ULK1 complex impairment: ULK1 complex signaling is compromised due to aberrant AMPK and mTOR regulation^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}

• mTOR dysregulation: mTOR overactivation phosphorylates and inhibits ULK1, preventing autophagy initiation^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}

• Aβ interference: Aβ oligomers directly interfere with autophagy initiation through multiple mechanisms^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}

• TRIM22 scaffolding: TRIM22 functions as a scaffold protein for autophagy initiation by binding Beclin-1^{8Park H, Heo H, Song Y et al., TRIM22 functions as a scaffold protein for autophagy initiation, Nat Commun, 20242024 · PMID 40337095Open reference}

• AMBRA1 regulation: AMBRA1 plays a critical role in mitophagy regulation^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}0

• Therapeutic activation: Magnolol activates the AMPK/mTOR/ULK1 pathway to restore autophagy in AD models^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}1

The reduction in Beclin-1 creates a bottleneck in autophagosome nucleation, while mTOR hyperactivation prevents the ULK1 complex from initiating autophagy despite cellular stress signals^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}2.

2. Lysosomal Dysfunction

Lysosomes are the final degradative compartments in the autophagy-lysosomal pathway^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}3. In AD, lysosomal function is compromised at multiple levels:

• Cathepsin reduction: Cathepsin D and other hydrolytic enzyme activities are significantly reduced in AD brain^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}4

• Membrane permeability: Lysosomal membrane permeability increases, leading to leakage of hydrolytic enzymes into the cytoplasm^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}5

• Acidification impairment: Lysosomal acidification is compromised, reducing the activity of pH-dependent hydrolases^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}6

• Aβ accumulation: Aβ accumulates within lysosomes, where it can damage lysosomal membranes and initiate a feed-forward cycle of dysfunction^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}7

• Microglial dysfunction: Lysosomal acidification dysfunction in microglia is an emerging pathogenic mechanism of neuroinflammation and neurodegeneration^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}8

• TRIM16-mediated lysophagy: TRIM16-mediated lysophagy suppresses Aβ accumulation in neurons^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}9

The lysosomal deficits in AD result in incomplete degradation of autophagic cargo, leading to the characteristic accumulation of autophagosomes and lipofuscin in affected neurons^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}0.

3. Impaired Autophagosome-Lysosome Fusion

Fusion between autophagosomes and lysosomes requires the coordinated action of SNARE proteins and the HOPS complex^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}1. In AD, this fusion process is severely compromised:

• Syntaxin-17 reduction: The SNARE protein syntaxin-17 is reduced in AD brain, impairing autophagosome-lysosome fusion^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}2

• HOPS complex alteration: Components of the HOPS tethering complex are altered, reducing fusion efficiency^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}3

• VAMP8 compromise: VAMP8-mediated fusion is compromised due to altered SNARE complex assembly^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}4

• Autophagosome accumulation: The combined defects lead to accumulation of undegraded autophagosomes in neuronal soma^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}5

This fusion defect represents a critical bottleneck in the autophagy-lysosomal pathway, as even with normal autophagosome formation and lysosomal function, the inability to fuse these compartments prevents cargo degradation^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}6.

4. Mitophagy Defects

Mitochondrial quality control through mitophagy is essential for neuronal survival^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}7. In AD, PINK1/Parkin-dependent mitophagy is impaired at multiple levels:

• PINK1 stabilization failure: PINK1 stabilization on damaged mitochondria is reduced in AD, preventing the initiation of parkin recruitment^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}8

• Parkin recruitment impairment: Parkin recruitment to depolarized mitochondria is compromised due to altered PINK1 dynamics^{3'Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009'2009 · PMID 18951747Open reference}9

• Ubiquitination defects: Ubiquitination of mitochondrial proteins is impaired, reducing the tagging of damaged mitochondria for degradation^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}0

• Drp1 dysregulation: Drp1-mediated mitochondrial fission is dysregulated, leading to abnormal mitochondrial morphology and function^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}1

• Therapeutic rescue: Urolithin A improves AD cognition and restores mitophagy and lysosomal functions^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}2

• Spautin-1 benefit: Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves learning in AD models^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}3

• BOK-mediated mitophagy: BOK-engaged mitophagy alleviates neuropathology in AD^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}4

• Mitochondrial dysfunction: Mitochondrial dysfunction is a central feature of AD^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}5

The accumulation of damaged mitochondria increases reactive oxygen species (ROS) production, creating additional oxidative stress that further impairs cellular homeostasis^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}6.

5. ER-Phagy (Reticulophagy) Defects

The endoplasmic reticulum is a major site of protein folding and calcium storage^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}7. In AD, ER-phagy (also called reticulophagy) is impaired:

• FAM134B dysfunction: FAM134B, the ER-phagy receptor, shows reduced functionality in AD neurons^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}8

• Atg40 impairment: Atg40-mediated ER remodeling and turnover is compromised^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}9

• ER stress accumulation: ER stress accumulates due to impaired clearance of damaged ER components^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}0

• Calcium dysregulation: ER calcium dysregulation contributes to protein misfolding and cellular stress^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}1

The accumulation of stressed ER contributes to protein misfolding and activates the unfolded protein response (UPR), which becomes chronic and maladaptive in AD^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}2.

6. TFEB and Lysosomal Biogenesis

TFEB is the master transcriptional regulator of the CLEAR (Coordinated Lysosomal Expression and Regulation) network, controlling over 400 genes involved in lysosomal biogenesis and autophagy^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}3. In AD, TFEB function is compromised:

• Nuclear translocation reduction: TFEB nuclear translocation is significantly reduced in AD neurons^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}4

• CLEAR network impairment: The coordinated lysosomal expression network is impaired due to reduced TFEB activity^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}5

• mTOR overactivation: mTOR overactivation inhibits TFEB by phosphorylating Ser211, trapping it in the cytoplasm^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}6

• Therapeutic potential: Pharmacological activation of TFEB shows promise in preclinical AD models^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}7

• Mechanistic insights: Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases provide new therapeutic targets^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}8

• Neuronal death: Autophagy-lysosomal-associated neuronal death is a key pathological mechanism^{2'Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008'2008 · PMID 18635956Open reference}9

TFEB represents a key therapeutic target, as its activation can simultaneously enhance lysosomal biogenesis, autophagy flux, and clearance of Aβ and tau pathology^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}0.

Autophagy Dysregulation in AD Pathogenesis

Therapeutic Strategies

Autophagy Induction

Multiple approaches can induce autophagy in AD^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}1:

• mTOR inhibitors: Rapamycin and everolimus inhibit mTORC1, releasing ULK1 and TFEB to activate autophagy^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}2

• AMPK activators: AICAR activates AMPK, which directly phosphorylates and activates ULK1^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}3

• Natural compounds: Resveratrol and curcumin can activate autophagy through multiple mechanisms^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}4

Lysosomal Function Enhancement

Enhancing lysosomal function can restore degraded cargo clearance^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}5:

• Cathepsin activators: Small molecules that enhance cathepsin activity within lysosomes^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}6

• TFEB overexpression: Gene therapy approaches using AAV-mediated TFEB delivery show promise^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}7

• Lysosomal acidification agents: Restoring lysosomal pH improves hydrolase activity^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}8

Autophagy-Lysosome Fusion Enhancement

Improving fusion efficiency can bypass multiple upstream defects^{4'Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer''s disease, Journal2008 · PMID 18653664Open reference}9:

• SNARE protein upregulation: Enhancing syntaxin-17 and VAMP8 expression^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}0

• HOPS complex stabilization: Stabilizing HOPS complex components to improve tethering^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}1

Advanced Therapeutic Strategies

PINK1/Parkin-Dependent Mitophagy Activation: The PINK1/Parkin pathway is the canonical mechanism for mitochondrial quality control^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}2. In AD, this pathway is impaired at multiple stages^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}3:

• PINK1 stabilization on damaged mitochondria is reduced^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}4

• Parkin recruitment to depolarized mitochondria is compromised^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}5

• Ubiquitination of mitochondrial proteins is impaired^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}6

• Therapeutic strategies include^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}7:

  • PINK1 stabilizers that prevent degradation

  • Parkin activators that enhance E3 ligase activity^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}8

  • Mitochondrial-targeted antioxidants to prevent depolarization^{5AMPK and mTOR regulate autophagy through ULK1 phosphorylation, Nat Cell Biol, 20112011 · PMID 21258367Open reference}9

• Targeting mitophagy is a promising therapeutic strategy for neurodegenerative diseases ^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}0

• SIRT5-mediated desuccinylation of RAB7A protects against Aβ-induced pathology by restoring autophagic flux ^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}1

NLRP3 Inflammasome and Autophagy Crosstalk: The NLRP3 inflammasome links autophagy dysfunction to neuroinflammation in AD^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}2:

• Impaired autophagy leads to ASC speck accumulation, which activates NLRP3^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}3

• NLRP3 activation triggers caspase-1 and IL-1β release, promoting inflammation^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}4

• Inflammation further impairs autophagy, creating a vicious cycle^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}5

• Autophagy enhancers reduce NLRP3-mediated inflammation through cargo clearance^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}6

• Dual-targeting approaches addressing both inflammation and autophagy may provide synergistic benefits^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}7

• Lysosomal acidification dysfunction in microglia is an emerging pathogenic mechanism linking neuroinflammation and neurodegeneration^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}8

Chaperone-Mediated Autophagy Enhancement: Chaperone-mediated autophagy (CMA) selectively degrades specific proteins bearing a KFERQ motif^{6Saxton RA, Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 20172017 · PMID 28388417Open reference}9. In AD, CMA is impaired:

• LAMP-2A decline: LAMP-2A receptor expression declines significantly with age and in AD^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}0

• LAMP2 family: LAMP2 family proteins (LAMP2A, LAMP2B, LAMP2C) have similar structures but divergent roles in lysosomal function^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}1

• Tau degradation: CMA impairment contributes to tau accumulation, as tau is a CMA substrate^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}2

• Therapeutic restoration: Enhancing LAMP-2A expression restores CMA activity and reduces pathological proteins^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}3

• CMA modulators: Small molecule modulators targeting LAMP-2A represent a targeted therapeutic approach^{7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference}4

Pharmacological Approaches in Development:

Compound	Mechanism	Status	Reference
Rapamycin	mTOR inhibition	Preclinical	7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference5
Trehalose	mTOR-independent autophagy	Preclinical	7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference6
Urolithin A	Mitophagy induction	Phase 2	7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference7
Genistein	TFEB activation	Preclinical	7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference8
Spautin-1	PINK1/Parkin activation	Preclinical	7Amyloid beta oligomers promote autophagic-lysosomal dysfunction through mTORC1 hyperactivation, Neurobiol Aging, 20192019 · PMID 31302316Open reference9
Remoglifozil	GABAA receptor mod	Phase 2	8Park H, Heo H, Song Y et al., TRIM22 functions as a scaffold protein for autophagy initiation, Nat Commun, 20242024 · PMID 40337095Open reference0
Latrepirdine	Autophagy enhancement	Phase 3	8Park H, Heo H, Song Y et al., TRIM22 functions as a scaffold protein for autophagy initiation, Nat Commun, 20242024 · PMID 40337095Open reference1

Summary

Autophagy-lysosomal dysfunction is a central pathological mechanism in AD, creating a vicious cycle where impaired protein clearance leads to toxic aggregate accumulation, which further disrupts cellular degradation pathways^{8Park H, Heo H, Song Y et al., TRIM22 functions as a scaffold protein for autophagy initiation, Nat Commun, 20242024 · PMID 40337095Open reference}2. Enhancing autophagy represents a promising therapeutic approach for AD^{8Park H, Heo H, Song Y et al., TRIM22 functions as a scaffold protein for autophagy initiation, Nat Commun, 20242024 · PMID 40337095Open reference}3.